- Available Technologies
Dr. Jeremy Mercuri is the John Witherspoon Gilpin MD ’82 Endowed Associate Professor of Bioengineering at Clemson University. He is also Director of the Laboratory of Orthopaedic Tissue Regeneration and Orthobiologics and is Deputy Director of the Clemson University Biomedical Engineering Innovation Campus (CUBEInC).
Dr. Mercuri received his undergraduate degree in Biomedical Engineering from Drexel University in 2003. He completed his Master’s and PhD in Bioengineering at Clemson University in 2006 and 2011, respectively. Following his doctoral work, Dr. Mercuri obtained a clinical post-doctoral fellowship at the Steadman Hawkins Clinic of the Carolinas in Greenville, South Carolina. Prior to his current academic appointment, Dr. Mercuri spent several years as a senior research engineer in the medical device industry working in the areas of biomechanical testing and biomaterials development for Medtronic Spine & Biologics and Stryker Orthobiologics, respectively. Dr. Mercuri currently serves as
the Chief Scientific Officer for Samaritan Biologics, LLC and is the founder and Chief Scientific Officer of NovaVia Spine & Biologics, LLC.
Dr. Mercuri’s academic research program focuses on developing biomimetic extracellular matrix (ECM)-based scaffolds designed for the repair and regeneration of herniated intervertebral discs, osteochondral defects, and damaged rotator cuff tendons. Dr. Mercuri’s lab also evaluates the efficacy of different mesenchymal stem cell sources as therapies for a variety of musculoskeletal conditions by employing both in vitro and in vivo models.
Stay up-to-date with the latest trends in the innovation and research industry. Sign up for our newsletter to see how CURF is making a difference and impacting the economy where we live.